J W Hollifield

Author PubWeight™ 43.00‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Effects of caffeine on plasma renin activity, catecholamines and blood pressure. N Engl J Med 1978 2.50
2 Suppression of plasma renin activity by indomethacin in man. Circ Res 1976 1.62
3 Plasma binding and the affinity of propranolol for a beta receptor in man. Clin Pharmacol Ther 1976 1.62
4 Proposed mechanisms of propranolol's antihypertensive effect in essential hypertension. N Engl J Med 1976 1.47
5 Thiazide diuretics, hypokalemia and cardiac arrhythmias. Acta Med Scand Suppl 1981 1.45
6 Sustained hypertension after section of the glossopharyngeal nerve. Am J Med 1977 1.30
7 Revascularization of the poorly functioning kidney. Surgery 1979 1.30
8 Primary aldosteronism: diagnosis, localization, and treatment. Ann Intern Med 1979 1.26
9 The influence of cholestyramine on thyroxine absorption. JAMA 1969 1.22
10 Prognostic factors in adrenal cortical tumors. A mathematical analysis of clinical and morphologic data. Am J Clin Pathol 1979 1.22
11 Renovascular hypertension: anatomic and renal function changes during drug therapy. Arch Surg 1981 1.21
12 Operative management of renovascular hypertension. Results after a follow-up of fifteen to twenty-three years. J Vasc Surg 1984 1.20
13 The prostaglandin system. A role in canine baroreceptor control of renin release. Circ Res 1978 1.03
14 Prostaglandins are overproduced by the kidneys and mediate hyperreninemia in Bartter's syndrome. Trans Assoc Am Physicians 1976 1.02
15 Thiazide treatment of hypertension. Effects of thiazide diuretics on serum potassium, magnesium, and ventricular ectopy. Am J Med 1986 1.02
16 Inhibition of propranolol metabolism by chlorpromazine. Clin Pharmacol Ther 1979 0.96
17 Potassium and magnesium abnormalities: diuretics and arrhythmias in hypertension. Am J Med 1984 0.94
18 Magnesium depletion, diuretics, and arrhythmias. Am J Med 1987 0.93
19 Renin-secreting clear cell carcinoma of the kidney. Arch Intern Med 1975 0.93
20 Influence of hypertonic saline on canine renal blood flow and renin release. Am J Physiol 1979 0.92
21 The participation of prostaglandins in the control of renin release. Fed Proc 1979 0.91
22 Reduction of plasma renin activity by inhibition of the fatty acid cyclooxygenase in human subjects: independence of sodium retention. Circ Res 1979 0.90
23 Progression of renal artery fibromuscular dysplasia in 42 patients as seen on angiography. Radiology 1981 0.88
24 Alterations in the responses of the sympathetic nervous system and renin in borderline hypertension. Hypertension 1981 0.86
25 Effectiveness of twice-daily dosage of methyldopa in essential hypertension. J Tenn Med Assoc 1978 0.84
26 Biochemical consequences of diuretic therapy in hypertension. J Tenn Med Assoc 1978 0.83
27 Bilateral renal artery stenosis and renovascular hypertension. Surgery 1977 0.82
28 The effects of benazepril, a new angiotensin-converting enzyme inhibitor, in mild to moderate essential hypertension: a multicenter study. Clin Pharmacol Ther 1991 0.81
29 Papilledema in two patients with acromegaly and intrasellar pituitary tumors. Arch Intern Med 1981 0.80
30 Study of the renal pressor system in experimental coarctation of the abdominal aorta. Am Surg 1977 0.80
31 Evidence for a new mineralocorticoid in patients with low-renin essential hypertension. Circ Res 1975 0.80
32 Saralasin infusion in the recognition of renovascular hypertension. Ann Intern Med 1977 0.80
33 D-xylose: active intestinal transport in a sodium ion substituted lithium medium. Nature 1967 0.80
34 Renal carcinoma discovered incidentally by arteriography during evaluation for hypertension. J Urol 1976 0.79
35 Effects of various adrenal inhibitors in low-renin essential hypertension. J Steroid Biochem 1977 0.78
36 Analysis of renal prostaglandin synthesis by competitive protein binding assay and gas chromatography--mass spectrometry. Adv Prostaglandin Thromboxane Res 1976 0.77
37 The prediction of anatomical morphology of primary aldosteronism using serum 18-hydroxycorticosterone levels. J Clin Endocrinol Metab 1985 0.77
38 Primary aldosteronism: computerized tomography in preoperative evaluation. South Med J 1985 0.77
39 Hypertension screening. J Tenn Med Assoc 1974 0.77
40 Gram-negative bacillary meningitis therapy. Polyradiculitis following intralumbar aminoglycoside administration. JAMA 1976 0.76
41 Assessment of the levels of pga2 in human plasma by gas chromatography-mass spectrometry. Prostaglandins 1975 0.76
42 Study of sar-ala8 angiotensin II (saralasin) responsiveness in hypertension of renal origin. J Surg Res 1978 0.76
43 Treatment of low-renin essential hypertension. Comparison of spironolactone and a hydrochlorothiazide-triamterene combination. JAMA 1974 0.76
44 Licorice intoxication. J Tenn Med Assoc 1975 0.75
45 Active transport of fluoride by the rat intestine in vitro. Biochim Biophys Acta 1966 0.75
46 The C19-mineralocorticoids in hypertension. Circ Res 1977 0.75
47 [Surgical treatment of renovascular hypertension: results of operation in 400 patients with renal artery stenosis (author's transl)]. Wien Klin Wochenschr 1980 0.75
48 Angiotensin-converting enzyme inhibition: a new medical therapy for hypertension? J Tenn Med Assoc 1978 0.75
49 Angiotensin II blockade by saralasin in the evaluation of hypertension in children. Kidney Int Suppl 1979 0.75
50 Serum magnesium and potassium levels in hypertensive patients after a therapeutic switch from hydrochlorothiazide plus a potassium supplement to maxzide. Am J Med 1987 0.75
51 Compliance in hypertension. J Tenn Med Assoc 1978 0.75
52 Percutaneous transluminal renal angioplasty (PTRA). J Tenn Med Assoc 1981 0.75
53 Metabolism of digitoxin in man and its modification by spironolactone. Eur J Clin Pharmacol 1976 0.75
54 Radionuclide evaluation of renal artery dilatation. Cardiovasc Intervent Radiol 1981 0.75
55 Failure of aspirin to antagonize the antihypertensive effect of spironolactone in low-renin hypertension. South Med J 1976 0.75
56 Prazosin. J Tenn Med Assoc 1976 0.75
57 Distinguishing primary aldosteronism caused by adenoma from adrenal hyperplasia. J Tenn Med Assoc 1978 0.75
58 Evidence for heterogeneity of mineralocorticoids in urine of patients with low renin essential hypertension. J Clin Endocrinol Metab 1979 0.75
59 Hypertension reviews: the incidence of low-renin essential hypertension in Davidson County, Tennessee hypertensives. J Tenn Med Assoc 1976 0.75
60 Hypertension and renal tumors. J Tenn Med Assoc 1975 0.75
61 Differentiation between malignant and benign solitary thyroid nodules by fluorescent scanning. J Nucl Med 1976 0.75
62 Are there unknown mineralocorticoids in low-renin essential hypertension? Mayo Clin Proc 1977 0.75
63 Effect of some organic acids in the incubation step on plasma renin activity. Clin Biochem 1980 0.75
64 Propranolol and diuretic combination in hypertension. J Tenn Med Assoc 1976 0.75
65 The clinical significance of plasma renin activity determination. J S C Med Assoc 1977 0.75
66 Evaluation of digital venous angiography for the diagnosis of renovascular hypertension. Radiology 1982 0.75
67 Screening recognition of primary aldosteronism. J Tenn Med Assoc 1977 0.75
68 Clinical significance of plasma renin activity. J Tenn Med Assoc 1973 0.75
69 Hypertension reviews. Licorice intoxication. J Tenn Med Assoc 1974 0.75
70 The hypertension of Cushing's syndrome. J Tenn Med Assoc 1976 0.75